相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio
Zengsheng Lu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang et al.
CELLS (2021)
Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat
Aziz Eftekhari et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
Tingting Yan et al.
ACTA PHARMACEUTICA SINICA B (2020)
Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
Zengsheng Lu et al.
BMC IMMUNOLOGY (2020)
A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
Weijian Mai et al.
FRONTIERS IN PHARMACOLOGY (2020)
Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes
Yanyan Wang et al.
PLOS ONE (2020)
Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes
Leyuan Li et al.
GUT MICROBES (2020)
Effects of berberine on intestinal flora of Non-alcoholic fatty liver induced by High-fat diet through 16S rRNA gene segmentation
Yuzhen Wang et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2020)
Hepatoprotective Role of Berberine on Doxorubicin Induced Hepatotoxicity - Involvement of Cyp
Bao Sun et al.
CURRENT DRUG METABOLISM (2020)
Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3
Xi Xu et al.
FASEB JOURNAL (2019)
Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
Yuanjun Deng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders
Sha Di et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
Lingyan Wu et al.
CELL DEATH & DISEASE (2019)
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
Xiaopeng Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Berberine ameliorates CCl4-induced liver injury in rats through regulation of the Nrf2-Keap1-ARE and p53 signaling pathways
Chun-Yang Han et al.
MOLECULAR MEDICINE REPORTS (2019)
Berberine and barberry (Berberis vulgaris): A clinical review
Mohsen Imenshahidi et al.
PHYTOTHERAPY RESEARCH (2019)
Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway
Yu-pei Zhang et al.
CURRENT MEDICAL SCIENCE (2019)
Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway
Hui Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats
Saeed Mehrzadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway
Chi Han Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper
Andrea Poli et al.
PHARMACOLOGICAL RESEARCH (2018)
Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats
Laila Ahmed Eissa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression
Jiying Du et al.
AMB EXPRESS (2018)
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
Jian Hui Xu et al.
MOLECULAR MEDICINE REPORTS (2017)
Berberine ameliorates non-alcoholic steatohepatitis in ApoE-/- mice
Jin Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Li Zhao et al.
BMC ENDOCRINE DISORDERS (2017)
Epigenetics and Liver Fibrosis
Eva Moran-Salvador et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats
Ayman M. Mahmoud et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-gamma and insulin receptor in a rat model of nonalcoholic fatty liver disease
Weihan Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress
Xiaoyan Qiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Drug-induced liver injury
D. Katarey et al.
CLINICAL MEDICINE (2016)
NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling
Elisa Vivoli et al.
CLINICAL SCIENCE (2016)
Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
Ning Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Xiaoyun Wei et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Post-inflationary gravitino production revisited
John Ellis et al.
JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS (2016)
Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Xinxia Chang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats
Xueyan Chen et al.
MOLECULAR MEDICINE REPORTS (2016)
Berberine acts as a putative epigenetic modulator by affecting the histone code
Zhixiang Wang et al.
TOXICOLOGY IN VITRO (2016)
TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells
Xiaoli Li et al.
SCIENTIFIC REPORTS (2016)
Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
Ting Guo et al.
SCIENTIFIC REPORTS (2016)
Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
Zhiguo Zhang et al.
SCIENTIFIC REPORTS (2016)
Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-B Signaling
Yongchen Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease
Raziye Iloon Kashkooli et al.
HEPATITIS MONTHLY (2015)
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
Xinlu Yuan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds
Sohair M. M. Ragab et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
Hong-Mei Yan et al.
PLOS ONE (2015)
The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice
Chunfen Mo et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Ali A. Mokdad et al.
BMC MEDICINE (2014)
Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells
Jin-Ching Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
A tale of 2 tissues: the overlapping role of scleraxis in tendons and the heart
Michael P. Czubryt
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2014)
Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Zheng Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice
Pengcheng Zhang et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells
Shatrunajay Shukla et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines
Mousa O. Germoush et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase
Jing Li et al.
LIFE SCIENCES (2014)
Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid
Chandraiah Godugu et al.
PLOS ONE (2014)
Role of Nrf2 in chronic liver disease
Wei Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
Martins Ekor
FRONTIERS IN PHARMACOLOGY (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
Douglas Marcotte et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride
Jia-Xiao Zhu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2013)
The burden of liver disease in Europe: A review of available epidemiological data
Martin Blachier et al.
JOURNAL OF HEPATOLOGY (2013)
Resolution of Liver Fibrosis by Isoquinoline Alkaloid Berberine in CCl4-Intoxicated Mice Is Mediated by Suppression of Oxidative Stress and Upregulation of MMP-2 Expression
Robert Domitrovic et al.
JOURNAL OF MEDICINAL FOOD (2013)
Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Karina G. Perez-Rubio et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth
Ya-Yun Hsu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
How to tackle rising rates of liver disease in the UK
Neeraj Bhala et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Protective Effects of Berberine on Doxorubicin-Induced Hepatotoxicity in Mice
Xiaoyan Zhao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Nrf2: A Potential Target for New Therapeutics in Liver Disease
A. M. Bataille et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells
Ya-Yun Hsu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients
Jing Yang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Berberine-induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases
Yeh-ching Linn et al.
PHYTOTHERAPY RESEARCH (2012)
Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCδ-GSK3β pathway
Hee Yeon Kay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats
Yang Qin-he et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2011)
Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine
Ting Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
Lian-Jun Xing et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
Tianjiong Lou et al.
INFLAMMATION (2011)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice
Robert Domitrovic et al.
TOXICOLOGY (2011)
Peroxisome proliferatoractivated receptor-gamma and the endothelium: implications in cardiovascular disease
Caroline Jane Magri et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2011)
Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery
Sunil Kumar Battu et al.
AAPS PHARMSCITECH (2010)
Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats
XinXia Chang et al.
JOURNAL OF LIPID RESEARCH (2010)
Epigenetic reprogramming of host genes in viral and microbial pathogenesis
Konstantinos Paschos et al.
TRENDS IN MICROBIOLOGY (2010)
Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats
Yibin Feng et al.
Chinese Medicine (2010)
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
Woo Sik Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Berberine Inhibits Hepatic Stellate Cell Proliferation and Prevents Experimental Liver Fibrosis
Xu Sun et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice
Yue-Min Nan et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors
Ben-Jian Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans
Feng Qiu et al.
DRUG METABOLISM AND DISPOSITION (2008)
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Mohsen Imanshahidi et al.
PHYTOTHERAPY RESEARCH (2008)
AMPK: a metabolic gauge regulating whole-body energy homeostasis
Ricardo Lage et al.
TRENDS IN MOLECULAR MEDICINE (2008)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Indian herbs and herbal drugs used for the treatment of diabetes
Manisha Modak et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry
Feng Zuo et al.
DRUG METABOLISM AND DISPOSITION (2006)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
WJ Holubek et al.
HEPATOLOGY (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Uncoupling protein-2 and non-alcoholic fatty liver disease
G Baffy
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Hepatobiliary excretion of berberine
PL Tsai et al.
DRUG METABOLISM AND DISPOSITION (2004)
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
D Accili et al.
CELL (2004)
Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells
MY Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
The involvement of P-glycoprotein in berberine absorption
GY Pan et al.
PHARMACOLOGY & TOXICOLOGY (2002)
PKB/AKT: Functional insights from genetic models
MP Scheid et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Oxidative stress-related molecules and liver fibrosis
M Parola et al.
JOURNAL OF HEPATOLOGY (2001)
Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27KIP1
PF Dijkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Mitochondrial adaptations to obesity-related oxidant stress
SQ Yang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Expression and function of PPARγ in rat and human vascular smooth muscle cells
RE Law et al.
CIRCULATION (2000)
Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents
KH Janbaz et al.
FITOTERAPIA (2000)
分享论文
